Duopharma Biotech independent director Dr Hasnita Hashim resigns

Bitget2026/09/30 09:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Duopharma Biotech reported the resignation of independent director Dr Hasnita Binti Hashim, effective Sept. 30, 2026.
Departure cited other professional commitments; no disagreement with the board was disclosed.
Hasnita holds a PhD in nuclear physics from Oxford; she is an associate of the Institute of Actuaries.
Career includes senior roles across Maybank’s investment banking and asset management businesses; she also serves as an independent director at Tenaga Nasional.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duopharma Biotech Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3710389) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Duopharma Biotech independent director Dr Hasnita Hashim resigns

You may also like

Crypto prices